KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) Assets Average (2016 - 2026)

Pfizer has reported Assets Average over the past 18 years, most recently at $208.1 billion for Q1 2026.

  • Quarterly Assets Average fell 1.25% to $208.1 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $208.1 billion through Mar 2026, down 1.25% year-over-year, with the annual reading at $210.8 billion for FY2025, 2.61% down from the prior year.
  • Assets Average was $208.1 billion for Q1 2026 at Pfizer, roughly flat from $208.6 billion in the prior quarter.
  • Over five years, Assets Average peaked at $223.8 billion in Q1 2024 and troughed at $118.2 billion in Q4 2022.
  • The 5-year median for Assets Average is $208.1 billion (2026), against an average of $198.3 billion.
  • Year-over-year, Assets Average skyrocketed 85.4% in 2023 and then fell 5.85% in 2025.
  • A 5-year view of Assets Average shows it stood at $119.1 billion in 2022, then skyrocketed by 85.4% to $220.8 billion in 2023, then dropped by 1.95% to $216.4 billion in 2024, then decreased by 3.63% to $208.6 billion in 2025, then decreased by 0.24% to $208.1 billion in 2026.
  • Per Business Quant, the three most recent readings for PFE's Assets Average are $208.1 billion (Q1 2026), $208.6 billion (Q4 2025), and $207.5 billion (Q3 2025).